Stockreport

Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Million

Sol-Gel Technologies Ltd.  (SLGL) 
Last sol-gel technologies ltd. earnings: 11/13 07:05 am Check Earnings Report
PDF -  Sol-Gel to receive $21 million over 24 months in exchange for the transfer of its rights to two marketed generic drugs and eight unapproved generic programs -  [Read more]